USPTO serial 79138261
ZYMENEX
Reviewed by CopyMark Law Group
Reg. 4774616Status 404
- Filing date
- Status date
- Registration date
- Jul 21, 2015
- Examiner
- MORRIS, KRISTINA KLOIBER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ZYMENEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary A. Donovan
Mary A. Donovan Cowan, Liebowitz & Latman, P.C.114 West 47th StreetNew York, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances, only available by a physician's prescription for medical purposes used in the field of human illnesses or deficiencies, namely, enzyme deficiency diseases including alpha-mannosidosis, galactocerebrosid-galactosidase including Krabbe Disease, and aspartylglucosaminidase to treat Aspartylglucosaminuria, porphobilinogen deaminase to treat porphyria illness including Acute Intermittent Porphyria and other diseases related thereto, none of the foregoing being enzyme preparations for dietary purposes; enzymes, enzyme-inhibitors, enzyme co-factors and enzyme related preparations, only available by a physician's prescription, all for medical purposes for the treatment of human illnesses or deficiencies, namely, enzyme deficiency diseases including alpha-mannosidosis, galactocerebrosid-galactosidase including Krabbe Disease, and aspartylglucosaminidase to treat Aspartylglucosaminuria, porphobilinogen deaminase to treat porphyria illness including Acute Intermittent Porphyria and other diseases related thereto, none of the foregoing being enzyme preparations for dietary purposes; diagnostic preparations only available by a physician's prescription for medical purposes used in the field of human illnesses or deficiencies, namely, enzyme deficiency diseases including alpha-mannosidosis, galactocerebrosid-galactosidase including Krabbe Disease, and aspartylglucosaminidase to treat Aspartylglucosaminuria, porphobilinogen deaminase to treat porphyria illness including Acute Intermittent Porphyria and other diseases related thereto, none of the foregoing being enzyme preparations for dietary purposes | SECTION 71 - CANCELLED | — |
| 009 | Computer software for use in database management in the fields of medicine, education and retail sales; website development software; communications software for connecting computer network users and global computer networks; downloadable electronic publications in the nature of books, magazines, periodicals and manuals in the field of medicine; electronic publications, namely, books, magazines, periodicals and manuals in the field of medicine, recorded on CD-ROMs and disks; and data processors | SECTION 71 - CANCELLED | — |
| 010 | Surgical and medical apparatus and instruments, namely, syringes and needles for medical purposes, inhalers and blood testing apparatus for use in the treatment of porphyria illness, lysosomal enzyme deficiency diseases, non-bacterial diseases and other diseases related thereto | SECTION 71 - CANCELLED | — |
| 016 | Publications, namely, books, magazines, printed periodicals and manuals in the fields of medicine and health; printed instructional or teaching matter in the fields of medicine and health; printed instructional material and printed treatment guides in the field of medicine and health issues; manuals concerning the installation and maintenance of computer software | SECTION 71 - CANCELLED | — |
| 041 | Providing education in the nature of seminars, training courses and instruction in the fields of medicine and information technology (IT) | SECTION 71 - CANCELLED | — |
| 042 | Scientific, industrial, biotechnological and biomedical research in the field of human illnesses or deficiencies, namely, porphyria illness, lysosomal enzyme deficiency diseases, non-bacterial diseases and other diseases related thereto and research concerning the medical treatment thereof; computer services, namely, providing a database featuring data concerning medical analysis and treatment, all for research purposes; designing, implementing and maintaining websites for others; computer network design and installation of computer software | SECTION 71 - CANCELLED | — |
| 044 | Providing medical information via the Internet; providing advice regarding personal management of medical conditions; providing advice to health professionals regarding medical conditions; providing medical information and medical counseling | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Zymenex A/S
- Other trademarks owned by Zymenex A/S
- Other trademarks owned by Zymenex A/S
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ZYMENEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Feb 12, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Dec 18, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Dec 18, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 30, 2023 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 13, 2023 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Apr 12, 2023 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Apr 12, 2023 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Oct 4, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 4, 2022 | C71T | CANCELLED SECTION 71 | — |
| Jul 21, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 13, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 13, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 8, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 20, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 9, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 8, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 18, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 9, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 9, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 21, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 21, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 11, 2015 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| May 5, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 5, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 24, 2015 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 15, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 15, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 15, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 8, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 8, 2015 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 31, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 27, 2015 | ALIE | ASSIGNED TO LIE | — |
| Mar 9, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 9, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 9, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 9, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 9, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 13, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 12, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 12, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 3, 2014 | RFNP | REFUSAL PROCESSED BY IB | — |
| Aug 14, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 14, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 14, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 22, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 21, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 21, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 22, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 22, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 21, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 20, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 13, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 19, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 13, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 11, 2013 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |